相似文献
1
From public health genomics to precision public health: a 20-year journey.
Genet Med. 2018 Jun;20(6):574-582. doi: 10.1038/gim.2017.211. Epub 2017 Dec 14.
2
Advancing precision public health using human genomics: examples from the field and future research opportunities.
Genome Med. 2021 Jun 1;13(1):97. doi: 10.1186/s13073-021-00911-0.
3
Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
OMICS. 2017 Nov;21(11):647-657. doi: 10.1089/omi.2017.0141.
4
Public Funding for Genomics and the Return on Investment: A Public Health Perspective.
Perspect Biol Med. 2018;61(4):572-583. doi: 10.1353/pbm.2018.0066.
5
Precision Medicine: From Science To Value.
Health Aff (Millwood). 2018 May;37(5):694-701. doi: 10.1377/hlthaff.2017.1624.
6
Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine?
Genet Med. 2010 Dec;12(12):785-91. doi: 10.1097/GIM.0b013e3182011222.
7
Precision Medicine and the Changing Landscape of Research Ethics.
Oncol Nurs Forum. 2016 Mar;43(2):149-50. doi: 10.1188/16.ONF.149-150.
8
Navigating the evidentiary turn in public health: Sensemaking strategies to integrate genomics into state-level chronic disease prevention programs.
Soc Sci Med. 2018 Aug;211:207-215. doi: 10.1016/j.socscimed.2018.06.026. Epub 2018 Jun 23.
9
Exploring priorities for public health genomics.
Genet Test Mol Biomarkers. 2011 Nov;15(11):741-2. doi: 10.1089/gtmb.2011.1525.
10
Exceptional opportunities in medical science: a view from the National Institutes of Health.
JAMA. 2015 Jan 13;313(2):131-2. doi: 10.1001/jama.2014.16736.
引用本文的文献
1
A Value Framework for Evaluating Population Genomic Programs: A Mixed Methods Approach.
J Pers Med. 2025 Jul 12;15(7):307. doi: 10.3390/jpm15070307.
2
Proceedings from the 2023 transdisciplinary conference for future leaders in precision public health "Applying Implementation Science to Precision Public Health".
BMC Proc. 2025 Jul 3;19(Suppl 14):17. doi: 10.1186/s12919-025-00332-6.
3
Analysing genome sequences and associated metadata during the COVID-19 pandemic in Iraq revealed points to be improved: An observational retrospective study.
PLoS One. 2025 Jun 30;20(6):e0326750. doi: 10.1371/journal.pone.0326750. eCollection 2025.
4
Reason and responsibility as a path toward ethical AI for (global) public health.
NPJ Digit Med. 2025 Jun 3;8(1):329. doi: 10.1038/s41746-025-01707-x.
5
Genomic and spatial epidemiology: lessons learned from SARS-CoV-2 pandemic.
Curr Opin HIV AIDS. 2025 May 1;20(3):287-293. doi: 10.1097/COH.0000000000000936. Epub 2025 Apr 1.
6
Tailored therapies for triple-negative breast cancer: current landscape and future perceptions.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 3. doi: 10.1007/s00210-025-03896-4.
7
Exploring the Role of Communication Asset Mapping (CAM) as a Strategy to Promote Hereditary Cancer Risk Assessment Information Within African American Communities.
Int J Environ Res Public Health. 2025 Jan 8;22(1):75. doi: 10.3390/ijerph22010075.
8
Adopting Public Health Genomics when the House Is on Fire: How Will We Navigate to 2030?
Public Health Genomics. 2025;28(1):53-65. doi: 10.1159/000543161. Epub 2025 Jan 2.
9
Changes in Skin Cancer-Related Behaviors, Distress, and Beliefs in Response to Receipt of Low- to Moderate-Penetrance Genetic Test Results for Skin Cancer Risk.
Cancers (Basel). 2024 Nov 30;16(23):4027. doi: 10.3390/cancers16234027.
10
Artificial Intelligence and Precision Public Health: A Balancing Act of Scientific Accuracy, Social Responsibility, and Community Engagement.
Port J Public Health. 2024 Mar 28;42(1):1-5. doi: 10.1159/000538141. eCollection 2024 Apr.
本文引用的文献
1
Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.
JAMA Pediatr. 2017 Sep 1;171(9):855-862. doi: 10.1001/jamapediatrics.2017.1755.
2
High-Throughput Sequencing as First-Tier Diagnostics in Congenital and Early-Onset Disorders.
JAMA Pediatr. 2017 Sep 1;171(9):833-835. doi: 10.1001/jamapediatrics.2017.1970.
3
Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing.
JAMA. 2017 Jul 25;318(4):381-382. doi: 10.1001/jama.2017.8543.
4
The human microbiome.
Adv Med Sci. 2017 Sep;62(2):414-420. doi: 10.1016/j.advms.2017.04.005. Epub 2017 Jul 13.
5
Advances in Public Health Surveillance and Information Dissemination at the Centers for Disease Control and Prevention.
Public Health Rep. 2017 Jul/Aug;132(4):403-410. doi: 10.1177/0033354917709542. Epub 2017 Jun 13.
6
Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research.
Genet Med. 2017 Oct;19(10):1081-1091. doi: 10.1038/gim.2017.21. Epub 2017 Apr 13.
7
Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data.
Genet Med. 2017 Aug;19(8):890-899. doi: 10.1038/gim.2016.209. Epub 2017 Jan 26.
8
Newborn Sequencing in Genomic Medicine and Public Health.
Pediatrics. 2017 Feb;139(2). doi: 10.1542/peds.2016-2252. Epub 2017 Jan 17.
9
A curated gene list for reporting results of newborn genomic sequencing.
Genet Med. 2017 Jul;19(7):809-818. doi: 10.1038/gim.2016.193. Epub 2017 Jan 12.
10
The current state of implementation science in genomic medicine: opportunities for improvement.
Genet Med. 2017 Aug;19(8):858-863. doi: 10.1038/gim.2016.210. Epub 2017 Jan 12.
Zotero 插件